In focus · trending topic

Obesity Drugs

1 stories · following the connections

Global Diabetes and Obesity Drugs Market to reach $163.2 Billion by 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment: ResearchMoz

By Nasdaq OMXSep 7, 2016, 12:01 PM UTC